FMLI
ALNY icon

Fukoku Mutual Life Insurance’s Alnylam Pharmaceuticals ALNY Stock Holding History

Fukoku Mutual Life Insurance’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-551
Closed -$251K – 248
2025
Q3 		$251K Sell
551
-108
-16% -$44K 0.02% 211
2025
Q2 		$215K Sell
659
-255
-28% -$70.6K 0.01% 251
2025
Q1 		$247K Hold
914
– – 0.02% 228
2024
Q4 		$215K Hold
914
– – 0.02% 256
2024
Q3 		$251K Hold
914
– – 0.02% 241
2024
Q2 		$222K Buy
+914
New +$144K 0.02% 251
2023
Q1 		– Sell
-1,430
Closed -$340K – 257
2022
Q4 		$340K Hold
1,430
– – 0.03% 176
2022
Q3 		$286K Sell
1,430
-150
-9% -$28.6K 0.03% 204
2022
Q2 		$230K Hold
1,580
– – 0.02% 241
2022
Q1 		$258K Hold
1,580
– – 0.02% 249
2021
Q4 		$268K Buy
1,580
+50
+3% +$9.29K 0.02% 244
2021
Q3 		$289K Buy
1,530
+230
+18% +$43.1K 0.02% 238
2021
Q2 		$220K Hold
1,300
– – 0.02% 259
2021
Q1 		$184K Hold
1,300
– – 0.02% 256
2020
Q4 		$169K Hold
1,300
– – 0.02% 259
2020
Q3 		$189K Buy
1,300
+200
+18% +$28.4K 0.02% 232
2020
Q2 		$163K Hold
1,100
– – 0.02% 235
2020
Q1 		$120K Hold
1,100
– – 0.02% 233
2019
Q4 		$127K Buy
1,100
+300
+38% +$29.9K 0.01% 275
2019
Q3 		$64K Hold
800
– – 0.01% 298
2019
Q2 		$58K Buy
800
+100
+14% +$7.67K 0.01% 301
2019
Q1 		$65K Hold
700
– – 0.01% 285
2018
Q4 		$51K Buy
700
+200
+40% +$15.4K 0.01% 294
2018
Q3 		$44K Hold
500
– – 0.01% 305
2018
Q2 		$49K Buy
500
+100
+25% +$9.92K 0.01% 297
2018
Q1 		$48K Hold
400
– – 0.01% 292
2017
Q4 		$51K Buy
+400
New +$50.3K 0.01% 286

Other funds holding ALNY

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Fukoku Mutual Life Insurance's ALNY Position: Q4 2025 in Review

Fukoku Mutual Life Insurance sold out of Alnylam Pharmaceuticals (ALNY) in Q4 2025, closing a stake of 551 shares — an estimated $251K sold.

Fukoku Mutual Life Insurance first reported a position in ALNY in Q4 2017 and held it in 27 quarters. The position peaked at $340K in Q4 2022. 851 funds tracked by Wall St. Rank hold ALNY as of Q4 2025.

  • Fukoku Mutual Life Insurance reported no remaining Alnylam Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Fukoku Mutual Life Insurance sold 551 Alnylam Pharmaceuticals shares in Q4 2025, an estimated $251K.
  • Fukoku Mutual Life Insurance first reported a position in Alnylam Pharmaceuticals in Q4 2017 and held it in 27 quarters.
  • Fukoku Mutual Life Insurance's Alnylam Pharmaceuticals position peaked at $340K in Q4 2022.
  • 851 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q4 2025.

Based on Fukoku Mutual Life Insurance's 13F filing for Q4 2025, filed 10 Feb 2026.